Different sympathetic pathways control the metabolism of distinct bone envelopes

Bone. 2012 May;50(5):1162-72. doi: 10.1016/j.bone.2012.01.023. Epub 2012 Feb 2.

Abstract

Bone remodeling, the mechanism that modulates bone mass adaptation, is controlled by the sympathetic nervous system through the catecholaminergic pathway. However, resorption in the mandible periosteum envelope is associated with cholinergic Vasoactive Intestinal Peptide (VIP)-positive nerve fibers sensitive to sympathetic neurotoxics, suggesting that different sympathetic pathways may control distinct bone envelopes. In this study, we assessed the role of distinct sympathetic pathways on rat femur and mandible envelopes. To this goal, adult male Wistar rats were chemically sympathectomized or treated with agonists/antagonists of the catecholaminergic and cholinergic pathways; femora and mandibles were sampled. Histomorphometric analysis showed that sympathectomy decreased the number of preosteoclasts and RANKL-expressing osteoblasts in mandible periosteum but had no effect on femur trabecular bone. In contrast, pharmacological stimulation or repression of the catecholaminergic cell receptors impacted the femur trabecular bone and mandible endosteal retromolar zone. VIP treatment of sympathectomized rats rescued the disturbances of the mandible periosteum and alveolar wall whereas the cholinergic pathway had no effect on the catecholaminergic-dependent envelopes. We also found that VIP receptor-1 was weakly expressed in periosteal osteoblasts in the mandible and was increased by VIP treatment, whereas osteoblasts of the retromolar envelope that was innervated only by tyrosine hydroxylase-immunoreactive fibers, constitutively expressed beta-2 adrenergic receptors. These data highlight the complexity of the sympathetic control of bone metabolism. Both the embryological origin of the bone (endochondral for the femur, membranous for the mandibular periosteum and the socket wall) and environmental factors specific to the innervated envelope may influence the phenotype of the sympathetic innervation. We suggest that an origin-dependent imprint of bone cells through osteoblast-nerve interactions determines the type of autonomous system innervating a particular bone envelope.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cholinergic Fibers / drug effects
  • Cholinergic Fibers / metabolism
  • Femur / cytology
  • Femur / drug effects
  • Femur / innervation*
  • Femur / metabolism*
  • Gene Expression Regulation / drug effects
  • Guanethidine / pharmacology
  • Isoproterenol / pharmacology
  • Macrophage Colony-Stimulating Factor / genetics
  • Macrophage Colony-Stimulating Factor / metabolism
  • Male
  • Mandible / cytology
  • Mandible / drug effects
  • Mandible / innervation*
  • Mandible / metabolism*
  • Osteogenesis / drug effects
  • Osteogenesis / genetics
  • Osteoprotegerin / genetics
  • Osteoprotegerin / metabolism
  • Periosteum / cytology
  • Periosteum / drug effects
  • Periosteum / innervation
  • Periosteum / metabolism
  • Propranolol / pharmacology
  • RANK Ligand / genetics
  • RANK Ligand / metabolism
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Wistar
  • Receptors, Adrenergic, beta-2 / metabolism
  • Receptors, Vasoactive Intestinal Peptide / metabolism
  • Sympathectomy
  • Sympathetic Nervous System / drug effects
  • Sympathetic Nervous System / metabolism*
  • Sympathetic Nervous System / surgery
  • Time Factors
  • Tyrosine 3-Monooxygenase / metabolism
  • Vasoactive Intestinal Peptide / pharmacology

Substances

  • Osteoprotegerin
  • RANK Ligand
  • RNA, Messenger
  • Receptors, Adrenergic, beta-2
  • Receptors, Vasoactive Intestinal Peptide
  • Vasoactive Intestinal Peptide
  • Macrophage Colony-Stimulating Factor
  • Propranolol
  • Tyrosine 3-Monooxygenase
  • Isoproterenol
  • Guanethidine